Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions

Bioorganic & Medicinal Chemistry
Prabhash Nath TripathiSushant K Shrivastava

Abstract

Novel hybrids bearing a 2-aminopyrimidine (2-AP) moiety linked to substituted 1,3,4-oxadiazoles were designed, synthesized and biologically evaluated. Among the developed compounds, 28 noncompetitively inhibited human acetylcholinesterase (hAChE; pIC50 = 6.52; Ki = 0.17 µM) and showed potential in vitro antioxidant activity (60.0%) when evaluated using the Ellman's and DPPH assays, respectively. Compound 28 competitively displaced propidium iodide (PI) from the peripheral anionic site (PAS) of hAChE (17.6%) and showed high blood-brain barrier (BBB) permeability, as observed in the PAMPA-BBB assay. Additionally, compound 28 inhibited hAChE-induced Aβ aggregation in a concentration-dependent manner according to the thioflavin T assay and was devoid of neurotoxic liability towards SH-SY5Y cell lines, as demonstrated by the MTT assay. The behavioral studies of compound 28 in mice showed a significant reversal of scopolamine-induced amnesia, as observed in Y-maze and passive avoidance tests. Furthermore, compound 28 exhibited significant AChE inhibition in the brain in ex vivo studies. An evaluation of oxidative stress biomarkers revealed the antioxidant potential of 28. Moreover, in silico molecular docking and dynamics simulation ...Continue Reading

References

Jun 1, 1966·Psychological Bulletin·W VogelJ G Draguns
Jun 1, 1966·The Biochemical Journal·E D Wills
Jul 1, 1994·Progress in Neurobiology·J SirviöP J Riekkinen
Nov 1, 1995·Brain Research. Brain Research Reviews·A Blokland
Jan 1, 1997·Free Radical Biology & Medicine·W R Markesbery
Nov 6, 2002·Journal of the Neurological Sciences·Wendy ThamChristopher P L-H Chen
Apr 2, 2003·European Journal of Medicinal Chemistry·Li DiGuy T Carter
May 21, 2003·Archives of Neurology·Angela L GuillozetM Marsel Mesulam
Jun 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Ruolan LiuMichel Baudry
Jun 27, 2003·Journal of Toxicology and Environmental Health. Part a·Y TangM M Mumtaz
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
May 14, 2004·Journal of Medicinal Chemistry·Athina A GeronikakiLiudmila Vlad
Sep 1, 2004·Expert Opinion on Drug Safety·Sarah ThompsonNathan Herrmann
Nov 28, 2006·Experimental Gerontology·Thanasekaran JayakumarPitchairaj Geraldine
Dec 19, 2009·Bioorganic & Medicinal Chemistry Letters·Pratibha Mehta LuthraSandeep Kumar Barodia
Apr 20, 2010·Neuroscience and Biobehavioral Reviews·Inge Klinkenberg, Arjan Blokland
May 18, 2010·Bioorganic & Medicinal Chemistry Letters·Tarek Mohamed, Praveen P N Rao
Aug 24, 2010·Molecular and Cellular Biochemistry·Klaudia JomovaMarian Valko
Dec 22, 2011·Journal of Medicinal Chemistry·Jonas BoströmAlleyn T Plowright
Aug 14, 2012·Neuropsychologia·Alexander EastonColin Lever
Oct 6, 2012·Journal of Medicinal Chemistry·Jonah CheungJude J Height
Jun 20, 2013·Journal of Chemical Information and Modeling·Koteswara Rao ValasaniShirley Shidu Yan
May 27, 2014·Current Environmental Health Reports·Christina R Tyler, Andrea M Allan
May 27, 2016·European Journal of Medicinal Chemistry·Jitendra KumarB Jayaram

❮ Previous
Next ❯

Citations

Aug 10, 2019·Bioorganic Chemistry·Niloufar ChoubdarMehdi Khoobi
Oct 3, 2020·Bioorganic & Medicinal Chemistry·Priyanka Kumari ChoubeySushant Kumar Shrivastava

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.